crashbandicoot4thewrathofcortex| Lepu Bio-B: Three clinical research results will be announced at the 2024 ASCO Annual Meeting

editor2024-05-24 08:47:2451

Lepu Bio-B (02157) issued an announcementcrashbandicoot4thewrathofcortex, the results of three clinical studies of the company's innovative drug candidates and combination therapies, including the antibody drug conjugate ('ADC ') MRG004A, the combination therapy of MRG003 and HX008, and the combination therapy of HX008 and nirapali, were announced at the 2024 American Society of Clinical Oncology ('ASCO') Annual Meeting.

crashbandicoot4thewrathofcortex| Lepu Bio-B: Three clinical research results will be announced at the 2024 ASCO Annual Meeting